88IV - Public company info - Clover Biopharmaceuticals Ltd.

Input the stock code or the company name

Clover Biopharmaceuticals Ltd., 02197.HK - Cash Flow	2020-12	2019-12
Net Cash Flow from Operating Activities	473,519	-27,400
Net Cash Flow from Return on Investments & Servicing of Finance	3,408	783
Interest Received	3,408	783
Interest Paid	0	0
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-394,120	-2,598
Additions to Fixed Assets	-113,614	-6,816
Disposal of Fixed Assets	0	0
Increase in Investments	0	0
Decrease in Investments	0	0
Net Cash Flow with Related Parties	0	0
Others	-280,506	4,218
Net Cash Flow before Financing Activities	82,807	-29,215
Net Cash Flow from Financing Activities	316,847	142,050
New Loans	0	0
Loans Repayment	-4,472	-1,726
Fixed Income/Debt Instruments	330,911	145,000
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	0	0
Net Cash Flow with Related Parties	0	0
Others	-9,592	-1,224
Increase(Decrease) in Cash & Cash Equivalents	399,654	112,835
Cash & Cash Equivalents at Beginning of Year	148,694	35,744
Net Cash Flow due to Change in Exchange Rate/Others	-32,164	115
Cash & Cash Equivalents at End of Year	516,184	148,694
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Clover Biopharmaceuticals Ltd. , 02197.HK